Biohaven Ltd. (BHVN)
(Real Time Quote from BATS)
$44.66 USD
-1.28 (-2.79%)
Updated Sep 24, 2024 02:08 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Biohaven Ltd. [BHVN]
Reports for Purchase
Showing records 1 - 20 ( 271 total )
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Takeaways From Biohaven''s Analyst Meeting; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Flexing the Issue: GLP-1 Agonists and the Quest for Balancing Weight Loss With Lean Muscle Preservation
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
1Q24 Updates; Reduce PT to $59 Due to Share Dilution
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
The Sequel Moves Towards the Main Scene; PT Up to $63 as Key Programs Advance
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Biohaven 2.0 Is a Sequel Worth Buying; Initiating Coverage at Buy With $50 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BHVN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 9/23/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 9/23/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 9/16/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 8/19/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 8/5/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
With PFE Acquisition On Track, Downgrading To Neutral Rating
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Neurology Prescription Sales Tracker -- Week Ending 7/29/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Biohaven Ltd.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department